Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Urol Nefrol (Mosk) ; (2): 32-4, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9206881

RESUMO

33 patients with benign prostatic hyperplasia (BPH) were exposed to hyperbaric oxygenation (HBO) and SHF waves. Group 1 patients had no prostatic inflammation, group 2 patients had combination of BPH with chronic prostatitis. Both these modalities are considered as to mechanism of action at different periods of the development of urination disturbances. The combined therapy imposed a positive trend in urination parameters, especially evident in group 2 patients. In them mean urination frequency reduced from 14.8-8.5 times to 6.3, mean urine volume increased from 83.6 to 199 ml. Index I-PSS fell in group 1 by 2 and group 2 by 6.4 scores. L index of quality of life declined by 1.2 and 1.6 scores in groups 1 and 2, respectively. It is inferred that combined use of HBO and SHF therapy is highly effective in urination disorders in patients with BPH suffering from or without chronic prostatitis.


Assuntos
Oxigenoterapia Hiperbárica , Micro-Ondas/uso terapêutico , Hiperplasia Prostática/terapia , Prostatite/terapia , Idoso , Doença Crônica , Terapia Combinada , Humanos , Oxigenoterapia Hiperbárica/métodos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
2.
Urol Nefrol (Mosk) ; (6): 37-9, 1996.
Artigo em Russo | MEDLINE | ID: mdl-9036608

RESUMO

16 males with benign prostatic hyperplasia (BPH) stage I-II received extremely high-frequency (EHF) therapy alone (group 1), 47 BPH males stage I-II and chronic nonspecific prostatitis EHF therapy plus antibacterial drugs (group 2). Group 3 was control. Clinical pretreatment parameters in group 1 averaged: IPSS--16.6; QOL--4.1; Qmax--7.2 ml/s, RU-135 ml. Three to six months of treatment brought the improvement: IPSS--14.7; QOL--3.2. Qmax rose to 8.3 ml/s, residual urine decreased to 126 ml in 11 (68.7%) patients. The effectiveness of the 2 group treatment was higher: initial IPSS--18.3, QOL-4.5, Qmax--9.2 ml/s, RU--62 ml changed for IPSS--14.1, QOL--3.1 in 43(91.5%) patients, obstruction diminished in 31 (65.9%) patients (Qmax--10.2 ml/s, RU--53 ml). EHF therapy proved effective and safe in BPH alone and especially in BPH combination with chronic nonspecific prostatis.


Assuntos
Micro-Ondas/uso terapêutico , Hiperplasia Prostática/radioterapia , Prostatite/radioterapia , Idoso , Doença Crônica , Terapia Combinada , Humanos , Masculino , Pessoa de Meia-Idade , Hiperplasia Prostática/tratamento farmacológico , Prostatite/tratamento farmacológico , Fatores de Tempo
3.
Urol Nefrol (Mosk) ; (3): 39-42, 1996.
Artigo em Russo | MEDLINE | ID: mdl-8928332

RESUMO

A 20-year follow-up (1975-1994) in urological clinic of 107 males with benign tumors of the urethra (BTU) has determined that most commonly encountered BTU comprise viral papillomas (67.3%), polyps (22.4%), angiomas (10.3%). Viral papillomas and angiomas locate as a rule in the hanging urethra, while polyps arise both in the anterior and posterior portions. Urethral polyps and angiomas manifest most frequently with hemospermia, urethrorrhagia and terminal macrohematuria after coitus or exertion. Chronic nonspecific urethritis is thought to be a factor predisposing to urethral condylomas and polyps. Viral papillomas originate from the external orifice and Morgagni fossa spreading proximally. BTU are diagnosed primarily at urethroscopy and managed with transurethral resection, electrocoagulation, partial urethral resection which proved curative in many cases.


Assuntos
Condiloma Acuminado/diagnóstico , Hemangioma/diagnóstico , Pólipos/diagnóstico , Doenças Uretrais/diagnóstico , Neoplasias Uretrais/diagnóstico , Adolescente , Adulto , Condiloma Acuminado/cirurgia , Eletrocoagulação , Hemangioma/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Pólipos/cirurgia , Doenças Uretrais/cirurgia , Neoplasias Uretrais/cirurgia
6.
Urol Nefrol (Mosk) ; (1): 59-62, 1990.
Artigo em Russo | MEDLINE | ID: mdl-2336760

RESUMO

The authors analysed the results of the surgical treatment of 167 patients with hydrocele who were operated on with the use of Winkelmann's or Bergmann's technique (group I), the same but modified by Grebenshchikov-Shevtsov's (group II), and Lord's method (group III). Sclerotherapy was employed in the group IV patients. A high percentage of complications was associated with Winkelmann and Bergmann's techniques (scrotal edema, hematoma, wound purulence) when the hydropic sac was isolated from the adjacent tissues. Postsurgical staying-in-bed time for those operated on with Winkelmann's and Bergmann's technique was mean 8.6 +/- 1.2 days and 9.4 +/- 1.3 days, respectively. When the same surgery was performed according to the Grebenshchikov-Shevtsov's modification a mean staying-in-bed time reduced to 7.2 +/- 0.9 days due to a lower incidence of postsurgical complications. Analysis of 42 surgeries performed with the Lord's method which avoided the isolation of the hydropic sac from the adjacent tissues demonstrated its efficacy and simplicity. No hematomas, suppurations or relapses were documented. The staying-in-bed time was 3.4 +/- 0.6 days. The pronounced changes in tunica propria and the multilocular character of hydrocele were the contradictions to this pattern of the treatment. In case the performance of the surgery was impossible, sclerotherapy with administration of 2-10 ml of 2.5 per cent of tetracycline solution was performed for the sclerosing and antibacterial effect. A mean staying-in-bed time was 2.1 +/- 0.9 days. Seven out of 8 patients recovered after 1-3 sessions of sclerotherapy.


Assuntos
Hidrocele Testicular/cirurgia , Adolescente , Adulto , Idoso , Doença Crônica , Estudos de Avaliação como Assunto , Seguimentos , Humanos , Masculino , Métodos , Pessoa de Meia-Idade , Recidiva , Escleroterapia/métodos , Testículo/cirurgia , Tetraciclina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...